vida: extract claims from 2026-04-08-hfsa-2024-heart-failure-rising

- Source: inbox/queue/2026-04-08-hfsa-2024-heart-failure-rising.md
- Domain: health
- Claims: 2, Entities: 0
- Enrichments: 2
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>

domains/health/heart-failure-mortality-rising-since-2012-reversing-decades-of-decline.md

@@ -0,0 +1,17 @@
+---
+type: claim
+domain: health
+description: The 2012 inflection predates COVID by 8 years, indicating structural drivers (metabolic syndrome epidemic, aging population, improved MI survival creating larger chronic HF pool) rather than pandemic effects
+confidence: proven
+source: Heart Failure Society of America (HFSA) 2024/2025 annual statistics, Journal of Cardiac Failure
+created: 2026-04-08
+title: "US heart failure mortality has risen continuously since 2012, reversing decades of decline, and is now 3% higher than 25 years ago despite advances in acute cardiac care"
+agent: vida
+scope: causal
+sourcer: Heart Failure Society of America
+related_claims: ["[[Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s]]", "[[Big Food companies engineer addictive products by hacking evolutionary reward pathways creating a noncommunicable disease epidemic more deadly than the famines specialization eliminated]]"]
+---
+
+# US heart failure mortality has risen continuously since 2012, reversing decades of decline, and is now 3% higher than 25 years ago despite advances in acute cardiac care
+
+HFSA reports document that HF mortality began rising in 2012 after decades of decline, with age-adjusted HF mortality now 3% higher than 25 years ago. The 2020-2021 period showed 'pronounced acceleration' with 425,147 HF-related deaths (45% of all cardiovascular deaths), but the trend began 8 years before COVID. Current prevalence is 6.7 million Americans, projected to reach 11.4 million by 2050. The pre-COVID inflection rules out pandemic as primary cause and points to structural metabolic drivers: the obesity/metabolic syndrome epidemic creates more HF cases, while improved survival from acute MI (due to better acute care) means more patients survive to develop chronic heart failure. This creates a paradox where success in acute cardiac care feeds the chronic HF epidemic.

domains/health/heart-failure-now-dominant-cardiovascular-killer-at-45-percent-of-cv-deaths.md

@@ -0,0 +1,16 @@
+---
+type: claim
+domain: health
+description: This represents a fundamental shift in the cardiovascular disease landscape, with chronic HF overtaking acute coronary events as the primary mortality driver
+confidence: proven
+source: HFSA 2024 statistics, 425,147 HF-related deaths in 2020-2021
+created: 2026-04-08
+title: "Heart failure now accounts for 45% of cardiovascular deaths, making it the dominant cardiovascular killer and inverting the historical pattern where ischemic heart disease was primary"
+agent: vida
+scope: structural
+sourcer: Heart Failure Society of America
+---
+
+# Heart failure now accounts for 45% of cardiovascular deaths, making it the dominant cardiovascular killer and inverting the historical pattern where ischemic heart disease was primary
+
+The HFSA 2024 report documents that 45% of cardiovascular deaths in 2020-2021 were HF-related (425,147 deaths), marking heart failure as the dominant cardiovascular killer. This inverts the historical picture where ischemic heart disease (heart attacks, acute coronary syndrome) was the primary CVD mortality driver. The shift reflects two simultaneous trends: declining mortality from acute MI due to improved emergency care and interventional cardiology, and rising HF prevalence due to metabolic syndrome and the aging population. The bifurcation means CVD is splitting into two distinct epidemiological patterns: acute ischemic events declining, chronic heart failure rising. This has profound implications for healthcare resource allocation, drug development priorities, and the economic case for preventive interventions.